Back
McEwen, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
54
MUX
McEwen, Inc.
Last Price:
$19.02
Seasonality Move:
19.43%
Sell
26
NVO
Novo Nordisk A/S
Last Price:
$50.17
Seasonality Move:
3.09%
Buy
54
McEwen, Inc. (MUX)
is a Buy
Is McEwen, Inc. a Buy, Sell or Hold?
-
The current McEwen, Inc. [MUX] share price is $19.04. The Score for MUX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
MUX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $50.18. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MUX Stock Price Chart
What is McEwen, Inc.'s stock price today?
-
The McEwen, Inc. share price today is $19.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MUX is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $50.18The current trend is relatively stagnant and NVO is experiencing slight selling pressure.
MUX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 56.09 | Buy |
| Chaikin Money Flow: | -789018 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.88 - 18.78) | Buy |
| Bollinger Bands (100): | (11.94 - 19.04) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 54.9 | Buy |
| Chaikin Money Flow: | -4526726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.65 - 49.41) | Buy |
| Bollinger Bands (100): | (47.99 - 58.53) | Sell |
MUX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.86 | Buy |
| 20-day SMA: | 18.03 | Buy |
| 50-day SMA: | 18.53 | Buy |
| 200-day SMA: | 11.98 | Buy |
| 8-day EMA: | 18.81 | Buy |
| 20-day EMA: | 18.36 | Buy |
| 50-day EMA: | 17.61 | Buy |
| 200-day EMA: | 13.52 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.26 | Buy |
| 20-day SMA: | 48.03 | Buy |
| 50-day SMA: | 51.08 | Sell |
| 200-day SMA: | 61.89 | Sell |
| 8-day EMA: | 48.72 | Buy |
| 20-day EMA: | 48.57 | Buy |
| 50-day EMA: | 50.6 | Sell |
| 200-day EMA: | 63.84 | Sell |
McEwen, Inc. Earnings Growth & MUX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $2.19 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and a decrease next year of $0.15 per share.
McEwen, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||